From the University of Cincinnati and Cincinnati Veterans Administration
Medical Center, Cincinnati, Ohio.
Correspondence to Gerald W. Dorn II, MD, University of Cincinnati and Cincinnati Veterans Administration Medical Center, 231 Bethesda Ave, ML 0542, Cincinnati, OH 45267-0542. E-mail DornGW{at}ucbeh.san.uc.edu
Background—Receptor-mediated
activation of myocardial Gq signaling is postulated as a biochemical
mechanism transducing pressure-overload hypertrophy. The
specific effects of Gq activation on the functional and morphological
adaptations to pressure overload are not known.
Methods and Results—To determine the effects of intrinsic myocyte
G
Conclusions—Intrinsic cardiac myocyte G
© 1998 American Heart Association, Inc.
Basic Science Reports
Decompensation of Pressure-Overload Hypertrophy in G
q-Overexpressing Mice
q signaling on the left ventricular hypertrophic
response to experimental pressure overload, transgenic mice
overexpressing Gq specifically in the heart (Gq-25) and
nontransgenic siblings underwent microsurgical creation of transverse
aortic coarctation and the morphometric, functional, and molecular
characteristics of these pressure-overloaded hearts were compared at
increasing times after surgery. Before aortic banding, isolated
Gq-25 ventricular myocytes exhibited contractile
depression (depressed +dl/dt and -dl/dt) and Gq-25 hearts showed a
pattern of fetal gene expression similar to the known characteristics
of nontransgenic pressure-overloaded mice. Three weeks after transverse
aortic banding, Gq-25 left ventricles hypertrophied to a similar
extent (
30% increase) as nontransgenic mice. However, whereas
nontransgenic mice exhibited concentric left ventricular
remodeling with maintained ejection performance (compensated
hypertrophy), Gq-25 left ventricles developed eccentric
hypertrophy and ejection performance deteriorated,
ultimately resulting in left heart failure (decompensated
hypertrophy). The signature
hypertrophy-associated progress of fetal cardiac gene
expression observed at baseline in Gq-25 developed after aortic
banding of nontransgenic mice but did not significantly change in
aortic-banded Gq-25 mice. q activation stimulates
fetal gene expression and depresses cardiac myocyte
contractility. Superimposition of the
hemodynamic stress of pressure overload on Gq
overexpression stimulates a maladaptive form of eccentric
hypertrophy that leads to rapid functional decompensation.
Therefore Gq-stimulated cardiac hypertrophy is
functionally deleterious and compromises the ability of the heart to
adapt to increased mechanical load. This finding supports a
reevaluation of accepted concepts regarding the mechanisms for
compensation and decompensation in pressure-overload
hypertrophy.
Key Words: hypertrophy • genetics • morphogenesis • ventricles • pressure
This article has been cited by other articles:
 |
|
 |
|
  A. J. Copik, C. Ma, A. Kosaka, S. Sahdeo, A. Trane, H. Ho, P. S. Dietrich, H. Yu, A. P. D. W. Ford, D. Button, et al. Facilitatory Interplay in {alpha}1a and {beta}2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction Mol. Pharmacol., March 1, 2009; 75(3): 713 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Patel and R. S. Ostrom An orphan GPCR finds a home in the heart Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H479 - H481. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Diwan, J. Wansapura, F. M. Syed, S. J. Matkovich, J. N. Lorenz, and G. W. Dorn II Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation Circulation, January 22, 2008; 117(3): 396 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Liggett, R. J. Kelly, R. R. Parekh, S. J. Matkovich, B. J. Benner, H. S. Hahn, F. M. Syed, A. S. Galvez, K. L. Case, N. McGuire, et al. A functional polymorphism of the G{alpha}q (GNAQ) gene is associated with accelerated mortality in African-American heart failure Hum. Mol. Genet., November 15, 2007; 16(22): 2740 - 2750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Diwan and G. W. Dorn II Decompensation of Cardiac Hypertrophy: Cellular Mechanisms and Novel Therapeutic Targets Physiology, February 1, 2007; 22(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-C. Fan, Q. Yuan, G. Song, Y. Wang, G. Chen, J. Qian, X. Zhou, Y. J. Lee, M. Ashraf, and E. G. Kranias Small Heat-Shock Protein Hsp20 Attenuates {beta}-Agonist-Mediated Cardiac Remodeling Through Apoptosis Signal-Regulating Kinase 1 Circ. Res., November 24, 2006; 99(11): 1233 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Smith and L. M. Luttrell Signal Switching, Crosstalk, and Arrestin Scaffolds: Novel G Protein-Coupled Receptor Signaling in Cardiovascular Disease Hypertension, August 1, 2006; 48(2): 173 - 179. [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Hoit Echocardiographic Characterization of the Cardiovascular Phenotype in Rodent Models Toxicol Pathol, January 1, 2006; 34(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Miyamoto, A. L. Howes, J. W. Adams, G. W. Dorn II, and J. H. Brown Ca2+ Dysregulation Induces Mitochondrial Depolarization and Apoptosis: ROLE OF Na+/Ca2+ EXCHANGER AND AKT J. Biol. Chem., November 18, 2005; 280(46): 38505 - 38512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Domenighetti, Q. Wang, M. Egger, S. M. Richards, T. Pedrazzini, and L. M.D. Delbridge Angiotensin II-Mediated Phenotypic Cardiomyocyte Remodeling Leads to Age-Dependent Cardiac Dysfunction and Failure Hypertension, August 1, 2005; 46(2): 426 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Syed, A. Odley, H. S. Hahn, E. W. Brunskill, R. A. Lynch, Y. Marreez, A. Sanbe, J. Robbins, and G. W. Dorn II Physiological Growth Synergizes With Pathological Genes in Experimental Cardiomyopathy Circ. Res., December 10, 2004; 95(12): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Harris, I. Treskov, M. W. Rowley, S. Heximer, K. Kaltenbronn, B. N. Finck, R. W. Gross, D. P. Kelly, K. J. Blumer, and A. J. Muslin G-Protein Signaling Participates in the Development of Diabetic Cardiomyopathy Diabetes, December 1, 2004; 53(12): 3082 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Onan, L. Pipolo, E. Yang, R. D. Hannan, and W. G. Thomas Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases Mol. Endocrinol., September 1, 2004; 18(9): 2344 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Selvetella, E. Hirsch, A. Notte, G. Tarone, and G. Lembo Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence Cardiovasc Res, August 15, 2004; 63(3): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Pan, T. Kislinger, A. O. Gramolini, E. Zvaritch, E. G. Kranias, D. H. MacLennan, and A. Emili Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics PNAS, February 24, 2004; 101(8): 2241 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Webster and N. H. Bishopric Apoptosis Inhibitors for Heart Disease Circulation, December 16, 2003; 108(24): 2954 - 2956. [Full Text] [PDF]
|
|
|
|
|
|
Y. Hayakawa, M. Chandra, W. Miao, J. Shirani, J. H. Brown, G. W. Dorn II, R. C. Armstrong, and R. N. Kitsis Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G{alpha}q Transgenic Mice Circulation, December 16, 2003; 108(24): 3036 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Hahn, Y. Marreez, A. Odley, A. Sterbling, M. G. Yussman, K. C. Hilty, I. Bodi, S. B. Liggett, A. Schwartz, and G. W. Dorn II Protein Kinase C{alpha} Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy Circ. Res., November 28, 2003; 93(11): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Dorn II, J. Robbins, and P. H. Sugden Phenotyping Hypertrophy: Eschew Obfuscation Circ. Res., June 13, 2003; 92(11): 1171 - 1175. [Full Text] [PDF]
|
|
|
|
|
|
C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure Cardiovasc Res, September 1, 2002; 55(4): 778 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Montgomery, B. M. Wolska, W. G. Pyle, B. B. Roman, J. C. Dowell, P. M. Buttrick, A. P. Koretsky, P. Del Nido, and R. J. Solaro alpha -Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2397 - H2405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. F Bueno, E. van Rooij, J. D Molkentin, P. A Doevendans, and L. J De Windt Calcineurin and hypertrophic heart disease: novel insights and remaining questions Cardiovasc Res, March 1, 2002; 53(4): 806 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kiriazis, Y. Sato, V. J Kadambi, A. G Schmidt, M. J Gerst, B. D Hoit, and E. G Kranias Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis Cardiovasc Res, February 1, 2002; 53(2): 372 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scheuermann-Freestone, N. S. Freestone, T. Langenickel, K. Hohnel, R. Dietz, and R. Willenbrock A new model of congestive heart failure in the mouse due to chronic volume overload Eur J Heart Fail, October 1, 2001; 3(5): 535 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, H. Hahn, G. Wu, C.-H. Chen, T. Liron, D. Schechtman, G. Cavallaro, L. Banci, Y. Guo, R. Bolli, et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and varepsilon PKC PNAS, September 5, 2001; (2001) 191369098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. ARONOW, T. TOYOKAWA, A. CANNING, K. HAGHIGHI, U. DELLING, E. KRANIAS, J. D. MOLKENTIN, and G. W. DORN II Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy Physiol Genomics, June 6, 2001; 6(1): 19 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-J. Du Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice Cardiovasc Res, June 1, 2001; 50(3): 443 - 453. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Feldman, J. M. Erikson, Y. Mao, C. E. Korcarz, R. M. Lang, and G. L. Freeman Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1698 - H1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Wang, X.-J. Du, D. J. Autelitano, C. A. Milano, and E. A. Woodcock Adverse effects of constitutively active alpha 1B-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1079 - H1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitarai, T. D. Reed, and A. Yatani Changes in ionic currents and beta -adrenergic receptor signaling in hypertrophied myocytes overexpressing Galpha q Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H139 - H148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mochly-Rosen, G. Wu, H. Hahn, H. Osinska, T. Liron, J. N. Lorenz, A. Yatani, J. Robbins, and G. W. Dorn II Cardiotrophic Effects of Protein Kinase C {epsilon} : Analysis by In Vivo Modulation of PKC{epsilon} Translocation Circ. Res., June 9, 2000; 86(11): 1173 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Redfern, M. Y. Degtyarev, A. T. Kwa, N. Salomonis, N. Cotte, T. Nanevicz, N. Fidelman, K. Desai, K. Vranizan, E. K. Lee, et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy PNAS, April 25, 2000; 97(9): 4826 - 4831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Liggett, N. M. Tepe, J. N. Lorenz, A. M. Canning, T. D. Jantz, S. Mitarai, A. Yatani, and G. W. Dorn II Early and Delayed Consequences of {beta}2-Adrenergic Receptor Overexpression in Mouse Hearts : Critical Role for Expression Level Circulation, April 11, 2000; 101(14): 1707 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Singh, C. Communal, D. B. Sawyer, and W. S. Colucci Adrenergic regulation of myocardial apoptosis Cardiovasc Res, February 1, 2000; 45(3): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jalili, Y. Takeishi, and R. A Walsh Signal transduction during cardiac hypertrophy: the role of G{alpha}q, PLC {beta}I, and PKC Cardiovasc Res, October 1, 1999; 44(1): 5 - 9. [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Cho, A. Rapacciuolo, W. J. Koch, Y. Kobayashi, L. R. Jones, and H. A. Rockman Defective beta -Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression J. Biol. Chem., August 6, 1999; 274(32): 22251 - 22256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Small, J.-F. Feng, J. Lorenz, E. T. Donnelly, A. Yu, M.-J. Im, G. W. Dorn II, and S. B. Liggett Cardiac Specific Overexpression of Transglutaminase II (Gh) Results in a Unique Hypertrophy Phenotype Independent of Phospholipase C Activation J. Biol. Chem., July 23, 1999; 274(30): 21291 - 21296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Engelhardt, L. Hein, F. Wiesmann, and M. J. Lohse Progressive hypertrophy and heart failure in beta 1-adrenergic receptor transgenic mice PNAS, June 8, 1999; 96(12): 7059 - 7064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice PNAS, May 25, 1999; 96(11): 6400 - 6405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Sugden Signaling in Myocardial Hypertrophy : Life After Calcineurin? Circ. Res., April 2, 1999; 84(6): 633 - 646. [Full Text] [PDF]
|
|
|
|
|
|
T. Meguro, C. Hong, K. Asai, G. Takagi, T. A. McKinsey, E. N. Olson, and S. F. Vatner Cyclosporine Attenuates Pressure-Overload Hypertrophy in Mice While Enhancing Susceptibility to Decompensation and Heart Failure Circ. Res., April 2, 1999; 84(6): 735 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Houser and E. G. Lakatta Function of the Cardiac Myocyte in the Conundrum of End-Stage, Dilated Human Heart Failure Circulation, February 9, 1999; 99(5): 600 - 604. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Dostal and K. M. Baker Angiotensin and Endothelin : Messengers That Couple Ventricular Stretch to the Na+/H+ Exchanger and Cardiac Hypertrophy Circ. Res., October 19, 1998; 83(8): 870 - 873. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Adams, Y. Sakata, M. G. Davis, V. P. Sah, Y. Wang, S. B. Liggett, K. R. Chien, J. H. Brown, and G. W. Dorn II Enhanced Galpha q signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure PNAS, August 18, 1998; 95(17): 10140 - 10145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. MacLellan and M. D. Schneider Success in Failure : Modeling Cardiac Decompensation in Transgenic Mice Circulation, April 21, 1998; 97(15): 1433 - 1435. [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, T. Toyokawa, H. Hahn, and G. W. Dorn II epsilon Protein Kinase C in Pathological Myocardial Hypertrophy. ANALYSIS BY COMBINED TRANSGENIC EXPRESSION OF TRANSLOCATION MODIFIERS AND Galpha q J. Biol. Chem., September 22, 2000; 275(39): 29927 - 29930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, H. Hahn, G. Wu, C.-H. Chen, T. Liron, D. Schechtman, G. Cavallaro, L. Banci, Y. Guo, R. Bolli, et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and varepsilon PKC PNAS, September 25, 2001; 98(20): 11114 - 11119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, F. Ishikura, S. Beppu, M. Asakura, S. Takashima, H. Asanuma, S. Sanada, J. Kim, H. Ogita, T. Kuzuya, et al. Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1703 - H1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wu, M. G. Yussman, T. J. Barrett, H. S. Hahn, H. Osinska, G. M. Hilliard, X. Wang, T. Toyokawa, A. Yatani, R. A. Lynch, et al. Increased Myocardial Rab GTPase Expression: A Consequence and Cause of Cardiomyopathy Circ. Res., December 7, 2001; 89(12): 1130 - 1137. [Abstract] [Full Text] [PDF]
|
|